PROTEOMIC PROFILING IN BLOOD IDENTIFIES NOVEL PRETREATMENT AND MECHANISTIC MARKERS RELATED TO INFLAMMATORY ADVERSE EVENTS IN RELAPSED/ REFRACTORY LARGE B-CELL LYMPHOMA AFTER AXICABTAGENE CILOLEUCEL Speth, K., Tiwari, G., Adhikary, S., Song, Q., Chou, J., Locke, F., Jacobson, C., Miklos, D., Oluwole, O., Kersten, M., Topp, M., Kim, J., Bot, A. BMJ PUBLISHING GROUP. 2022: A717

View details for DOI 10.1136/jitc-2022-SITC2022.0687

View details for Web of Science ID 000919423400646